PETER LANGECKER

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Oncotelic Therapeutics, Inc.

Filing Date Source Excerpt
2010-11-12 Peter Langecker(5) Includes options to purchase 181,250 shares of common stock, which are exercisable within 60 days of October 29, 2010 (December 28, 2010).
2011-02-18 Peter J. Langecker, M.D., Ph.D. Chief Executive Officer
2012-11-19 Peter J. Langecker, M.D., Ph.D. Chief Executive Officer

Data sourced from SEC filings. Last updated: 2025-10-11